Abstract |
Mucin 1 (MUC1) is a heterodimeric transmembrane glycoprotein that protects epithelial cells in mammals. The transmembrane C-terminal subunit (MUC1-C) plays a crucial role in oncogenesis. As an oncoprotein, MUC1-C regulates a number of proteins that are associated with tumorigenesis by interacting with oncoproteins, transcription factors, coactivators, etc., inducing proliferation, epithelial-mesenchymal transition (EMT), invasion, stemness, immune evasion, and drug resistance. Moreover, MUC1-C modulates the expression of non-coding RNAs (ncRNAs), which further regulate carcinogenesis by directly binding to specific proteins. ncRNAs can also affect MUC1 protein expression by targeting the MUC1 mRNA 3' untranslated region (UTR). A series of ncRNAs can modulate cancer development by regulating MUC1-C. This review focuses on the interaction of MUC1-C with proteins and ncRNAs in cancer progression. We also summarize the recent advances in immunotherapy with a focus on therapeutic approaches based on MUC1-C and nanocarrier complexes for cancer treatment.
|
Authors | Wei Li, Yineng Han, Chenmin Sun, Xue Li, Junhua Zheng, Jianping Che, Xudong Yao, Donald Kufe |
Journal | Theranostics
(Theranostics)
Vol. 12
Issue 3
Pg. 999-1011
( 2022)
ISSN: 1838-7640 [Electronic] Australia |
PMID | 35154471
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Copyright | © The author(s). |
Chemical References |
- MicroRNAs
- Mucin-1
- Oncogene Proteins
- RNA, Untranslated
|
Topics |
- Animals
- Cell Line, Tumor
- Epithelial-Mesenchymal Transition
(genetics)
- Mammals
(genetics, metabolism)
- MicroRNAs
(metabolism)
- Mucin-1
(metabolism)
- Neoplasms
(genetics, therapy)
- Oncogene Proteins
- RNA, Untranslated
(genetics)
|